Price $132.00 |
Market Cap
11.14B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
60.1
|
P/B
5.5
|
P/S
6.17
|
Dividend %
-
|
|
P/CF
149.9
|
P/FCF
29.8
|
Op. Cash Flow
409.4K
|
FCF
3.7
|
|
Op. Margin
11.40%
|
Net Margin
10.70%
|
ROE
10.50%
|
ROI
6.40%
|
|
ROA
7.50%
|
EPS Growth
223.10%
|
Current Ratio
2.7
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Cumberland Pharmaceuticals, In (CPIX) | $1.60 | - | - | 28.7M | Strong Buy |
| Interpace Biosciences Inc (IDXG) | $1.45 | - | - | 4.1M | Strong Buy |
| Jazz Pharmaceuticals PLC (JAZZ) | $109.94 | - | - | 8.13B | Strong Buy |
| Journey Medical Corp (DERM) | $3.48 | - | - | 43.3M | Strong Buy |
| KORU Medical Systems Inc (KRMD) | $2.08 | - | - | 103.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
